
No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CRSP | NASDAQ | USD | Real-time | |
CRSPN | Mexico | MXN | Delayed | |
1CG | Frankfurt | EUR | Delayed |
The stock market is vulnerable to a decline because of overvaluation, while "reopening" and cyclical stocks have been overplayed.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell | Strong Sell | Buy |
Technical Indicators | BUY | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Engulfing Bearish | 1M | Current | |||
Completed Patterns | |||||
Advance Block Bearish | 1M | 1 | Jan 21 | ||
Upside Gap Three Methods | 30 | 2 | Feb 25, 2021 20:30 | ||
Three Outside Down | 1W | 4 | Jan 24, 2021 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NASDAQ | 127.28 | 122.13 | 125.04 | 2,147,170 | -4.67% | USD | 25/02 | ||
Mexico | 2,650.00 | 2,630.00 | 2,636.75 | 235 | -2.75% | MXN | 25/02 | ||
Frankfurt | 40.0000 | 41.0000 | 41.2000 | 0 | 0.00% | EUR | 04/02 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Dangote Cement | 206.00 | 206.00 | 206.00 | -14.00 | -6.36% | 9.54K | 11:05:00 | ||
UBA | 8.20 | 8.35 | 8.00 | 0.00 | 0.00% | 9.96M | 11:12:00 | ||
Dangote Sugar | 18.00 | 18.00 | 18.00 | -0.10 | -0.55% | 1.66M | 11:15:00 | ||
Access Bank | 8.05 | 8.10 | 7.95 | -0.10 | -1.23% | 7.67M | 11:13:00 | ||
Cileasing | 5.16 | 5.16 | 5.16 | +0.03 | +0.58% | 510.94K | 11:07:00 | ||
FBN Holdings | 7.35 | 7.35 | 7.30 | -0.05 | -0.68% | 4.60M | 11:09:00 | ||
Ncr Nig | 3.55 | 3.55 | 3.55 | +0.00 | +0.00% | 0 | 19/02 | ||
Flour Mills of Nigeria | 27.10 | 27.10 | 27.10 | -1.75 | -6.07% | 60.69K | 11:06:00 | ||
Guiness Nigeria | 23.05 | 23.05 | 23.00 | +0.05 | +0.22% | 1.29M | 11:05:00 | ||
Mansard Ins | 1.050 | 1.050 | 1.040 | -0.070 | -6.25% | 3.04M | 10:54:00 |
CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which allows for precise directed changes to genomic deoxyribonucleic acid (DNA). The Company has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine and rare diseases. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient’s hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The Company has business operations in London and the United Kingdom, as well as research and development operations in the United States.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review